substance use disorder Archives

Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Apr. 2, 2021—Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

Tennessee Receives Grant from Federal Government to Address Opioid Crisis

Dec. 20, 2019—The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants.

Anne Hazlett, JD, senior adviser for Rural Affairs in the White House Office of National Drug Control Policy (ONDCP), recently visited Vanderbilt University Medical Center for a tour of the addiction Bridge Clinic. The multispecialty clinic is designed to bridge inpatient, emergency department and outpatient care for patients with substance use disorder who are leaving Vanderbilt University Adult Hospital or the emergency room and require follow-up care for their addiction. From left are Erica Brice, PhD; David Marcovitz, MD; Hazlett; Katie White, MD, PhD; Charlie Baldwin, JD; Jameson Norton, MBA; and David Edwards, MD, PhD.

Bridge Clinic tour

Sep. 25, 2019—Anne Hazlett, JD, senior adviser for Rural Affairs in the White House Office of National Drug Control Policy (ONDCP), recently visited Vanderbilt University Medical Center for a tour of the addiction Bridge Clinic.

VUMC Reporter

substance use disorder Archives

Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Tennessee Receives Grant from Federal Government to Address Opioid Crisis

Bridge Clinic tour

Recent Stories from VUMC News and Communications Publications